F.D.A. Needs to Be More Critical of the Industry It Oversees
The agency that regulates drug safety has become too cozy with the industry it’s supposed to oversee.
House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
Ivermectin Won’t Treat Covid-19, but Demand Is High Anyway
Clinical trials have repeatedly failed to show that the drug is effective against the virus. Still, U.S. demand is high.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.